Author

K. Owczarek

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Assay:whole-genome sequencing· 1

Frequent Co-Authors

A. Dabrowska· 3 shared K. Pyrc· 3 shared A. Milewska· 2 shared A. Szczepanski· 2 shared W. Branicki· 2 shared A. Czarna· 1 shared A. Kula-Pacurar· 1 shared A. Matsuda· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

A. Dabrowska

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Acriflavine, a clinically aproved drug, inhibits SARS-CoV-2 and other betacoronaviruses

V. Napolitano, A. Dabrowska, K. Schorpp, A. Mourao, E. Barreto-Duran, M. Benedyk, P. Botwina, S. Brandner, M. Bostock, Y. Chykunova, A. Czarna, G. Dubin, T. Frohlich, M. Hoelscher, M. Jedrysik, , K. Pyrc

This study identifies acriflavine as a potent inhibitor of SARS-CoV-2 and other betacoronaviruses, effective in cellular models, in vivo, and ex vivo.

bioRxiv · Mar 20, 2021Microbiology

The SARS-CoV-2 ORF10 is not essential in vitro or in vivo in humans.

K. Pancer, A. Milewska, K. Owczarek, A. Dabrowska, W. Branicki, M. Sanak, K. Pyrc

The paper shows that SARS-CoV-2 ORF10 is not essential for viral replication or disease in humans, based on clinical and in vitro evidence.

bioRxiv · Aug 29, 2020Microbiology

Replication of SARS-CoV-2 in human respiratory epithelium

A. Milewska, A. Kula-Pacurar, J. Wadas, A. Suder, A. Szczepanski, A. Dabrowska, K. Owczarek, M. Ochman, T. Stacel, Z. Rajfur, P. P. Labaj, W. Branicki, K. Pyrc

The paper presents a human airway epithelium model for studying SARS-CoV-2 replication and drug assessment, highlighting its potential as an alternative to animal models and Vero E6 cells.

bioRxiv · Mar 20, 2020Microbiology